Cargando…

Clinical utility of comprehensive genomic profiling in central nervous system tumors of children and young adults

BACKGROUND: Recent large-scale genomic studies have revealed a spectrum of genetic variants associated with specific subtypes of central nervous system (CNS) tumors. The aim of this study was to determine the clinical utility of comprehensive genomic profiling of pediatric, adolescent and young adul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Jianling, Kaneva, Kristiyana, Hiemenz, Matthew C, Dhall, Girish, Davidson, Tom Belle, Erdreich-Epstein, Anat, Hawes, Debra, Hurth, Kyle, Margol, Ashley S, Mathew, Anna J, Robison, Nathan J, Schmidt, Ryan J, Tran, Hung N, Judkins, Alexander R, Cotter, Jennifer A, Biegel, Jaclyn A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Basic and Translational Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080244/ https://www.ncbi.nlm.nih.gov/pubmed/33948563 http://dx.doi.org/10.1093/noajnl/vdab037

Ejemplares similares

The spectrum of mitochondrial DNA (mtDNA) mutations in pediatric CNS tumors
por: Kaneva, Kristiyana, et al.
Publicado: (2021)

Low-pass whole-genome and targeted sequencing of cell-free DNA from cerebrospinal fluid in pediatric patients with central nervous system tumors
por: O’Halloran, Katrina, et al.
Publicado: (2023)

RARE-21. A RARE CASE OF PEDIATRIC SPINDLE CELL ONCOCYTOMA WITH EML4-ALK FUSION
por: Michaiel, George, et al.
Publicado: (2021)

Sustained response of three pediatric BRAF(V600E) mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy
por: Toll, Stephanie A., et al.
Publicado: (2019)

Addendum: Sustained response of three pediatric BRAF(V600E) mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy
por: Toll, Stephanie A., et al.
Publicado: (2023)

RARE-16. A PATIENT WITH MOSAIC POST-ZYGOTIC KRAS-G12D PATHOGENIC VARIANT PRESENTING WITH A SYMPTOMATIC SPINAL NEUROFIBROMA AND LARGE SEGMENTAL TRUNCAL CAFÉ AU LAIT SPOT
por: Demaliaj, Dardan, et al.
Publicado: (2021)

TBIO-12. THE SPECTRUM OF MITOCHONDRIAl DNA (mtDNA) MUTATIONS IN PEDIATRIC CENTRAL NERVOUS SYSTEM (CNS) TUMORS
por: Kaneva, Kristiyana, et al.
Publicado: (2020)

RARE-57. PEDIATRIC CHORDOMA: WHOLE EXOME SEQUENCING OF 11 PEDIATRIC CHORDOMA SAMPLES
por: O’Halloran, Katrina, et al.
Publicado: (2020)

Transmission of a TP53 germline mutation from unaffected male carrier associated with pediatric glioblastoma in his child and gestational choriocarcinoma in his female partner
por: Cotter, Jennifer A., et al.
Publicado: (2018)

MEDB-86. A re-induction regimen for children with recurrent medulloblastoma
por: O'Halloran, Katrina, et al.
Publicado: (2022)

Quantitative Nuclear Histomorphometry Predicts Molecular Subtype and Clinical Outcome in Medulloblastomas: Preliminary Findings
por: Whitney, Jon, et al.
Publicado: (2022)

The mutational landscape of spinal chordomas and their sensitive detection using circulating tumor DNA
por: Mattox, Austin K, et al.
Publicado: (2020)

Early-onset grade 2-3 diffuse gliomas and schwannomas increase the risk of central nervous system tumors among the patients’ relatives
por: Alanen, Eljas, et al.
Publicado: (2023)

Single-cell transcriptomic analyses provide insights into the cellular origins and drivers of brain metastasis from lung adenocarcinoma
por: Wang, Zihao, et al.
Publicado: (2023)

GBMdeconvoluteR accurately infers proportions of neoplastic and immune cell populations from bulk glioblastoma transcriptomics data
por: Ajaib, Shoaib, et al.
Publicado: (2023)

Editorial: Developmental therapeutics in pediatric neuro-oncology
por: Makimoto, Atsushi, et al.
Publicado: (2023)

Rare central nervous system tumors in adults: a population-based study of ependymomas, pilocytic astrocytomas, medulloblastomas, and intracranial germ cell tumors
por: Ho, Vincent K Y, et al.
Publicado: (2022)

Histone deacetylase inhibition enhances the therapeutic effects of methotrexate on primary central nervous system lymphoma
por: Fujimoto, Kenji, et al.
Publicado: (2020)

Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors—A prospective study and guidelines for clinical testing
por: Galbraith, Kristyn, et al.
Publicado: (2023)

Use of rituximab, temozolomide, and radiation in recurrent and refractory primary central nervous system lymphoma in the Philippines: a retrospective analysis
por: Batara, Julette Marie F, et al.
Publicado: (2022)

A brain-penetrant microtubule-targeting agent that disrupts hallmarks of glioma tumorigenesis
por: Horne, Eric A, et al.
Publicado: (2020)

Brief Report: HIV-1 Evolution in Breakthrough Infections in a Human Trial of Oral Pre-exposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate
por: Ruone, Susan, et al.
Publicado: (2016)

Feasibility of Treating High Grade Gliomas in Children with Tumor-Treating Fields: A Case Series
por: Crawford, John, et al.
Publicado: (2020)

Raised cardiovascular disease mortality after central nervous system tumor diagnosis: analysis of 171,926 patients from UK and USA
por: Jin, Kai, et al.
Publicado: (2021)

MRI-guided focused ultrasound blood–brain barrier opening increases drug delivery and efficacy in a diffuse midline glioma mouse model
por: Martinez, Payton, et al.
Publicado: (2023)

Incidence trends in pediatric central nervous system tumors in Canada: a 15 years report from Cancer and Young People in Canada (CYP-C) registry
por: Larouche, Valérie, et al.
Publicado: (2020)

ELTD1 as a multi-focal target for malignant gliomas: preclinical studies
por: Zalles, Michelle, et al.
Publicado: (2021)

Comprehensive Genome Analysis of 6,000 USA SARS-CoV-2 Isolates Reveals Haplotype Signatures and Localized Transmission Patterns by State and by Country
por: Shen, Lishuang, et al.
Publicado: (2020)

EMBR-08. CORRELATION OF HISTOPATHOLOGY, CHROMOSOMAL MICROARRAY, AND NANOSTRING BASED 22-GENE ASSAY FOR MEDULLOBLASTOMA SUBGROUP ASSIGNMENT ON “HEAD START” 4 CLINICAL TRIAL
por: Dhall, Girish, et al.
Publicado: (2021)

MBCL-13. CORRELATION OF HISTOPATHOLOGY, CHROMOSOMAL MICROARRAY, AND NANOSTRING BASED 22-GENE ASSAY FOR MEDULLOBLASTOMA SUBGROUP ASSIGNMENT ON “HEAD START” 4 CLINICAL TRIAL
por: Dhall, Girish, et al.
Publicado: (2020)

Continuous and bolus intraventricular topotecan prolong survival in a mouse model of leptomeningeal medulloblastoma
por: Shackleford, Gregory M., et al.
Publicado: (2019)

Intracranially injectable multi-siRNA nanomedicine for the inhibition of glioma stem cells
por: Manju, Cheripelil Abraham, et al.
Publicado: (2021)

Rapidly emerging SARS-CoV-2 B.1.1.7 sub-lineage in the United States of America with spike protein D178H and membrane protein V70L mutations
por: Shen, Lishuang, et al.
Publicado: (2021)

Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications
por: Shen, Lishuang, et al.
Publicado: (2021)

Mitochondrial DNA haplogroup, genetic ancestry, and susceptibility to Ewing sarcoma
por: Kaneva, Kristiyana, et al.
Publicado: (2022)

Dysregulated bioenergetics: a key regulator of joint inflammation
por: Biniecka, M, et al.
Publicado: (2016)

Hospital admissions for stroke and bleeding in Hounslow following a quality improvement initiative
por: Wong, Kam Ying, et al.
Publicado: (2021)

Increased function of pronociceptive TRPV1 at the level of the joint in a rat model of osteoarthritis pain
por: Kelly, S, et al.
Publicado: (2015)

Glucocorticoids induce senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53/p21 pathway: in vivo and in vitro evidence
por: Poulsen, Raewyn C, et al.
Publicado: (2014)

Novel genetically engineered H3.3G34R model reveals cooperation with ATRX loss in upregulation of Hoxa cluster genes and promotion of neuronal lineage
por: Abdallah, Aalaa S, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mfv7192ljvsu0m7kr656fg65jt